•  

Tumour Models London

Part of the trusted Tumor Model series, Tumour Models London supports Pharma, Biotech, and Academia to best translate next generation In Vitro and In Vivo preclinical learnings to the clinic.

5 7 December 2017

Currently in read only mode, sorry about that, please try again in a few hours.

4 speakers

  • Frank Schnieders CEO, Provecs Medical
  • Michael Rugaard Jensen Head of Drug Discovery Pharmacology, Novartis
  • Dr. Vinagolu Rajasekhar Senior Research Scientist, Memorial Sloan Kettering Cancer Center
  • Daniel Hynes Preclinical Manager, E-therapeutics

1 session

Conferences Day 1 from 9am to 5pm Tuesday 5th December 2017

Add a session

Conferences Day 2 from 9am to 5pm Wednesday 6th December 2017

Add a session

Conferences Day 3 from 9am to 5pm Thursday 7th December 2017

Add a session

1 person tracking this event

  • evvnt Platform

Tell your friends!

Share this event with your friends on Twitter

Share

See something wrong?

Report an issue with this event